We support the use of nanotechnology to develop innovative drugs and vaccines that address the unmet medical needs of people and animals.
Nanotechnology involves the use of materials less than 100 nanometers in size (nanomaterials). This highly precise technology offers multi-faceted applications for commonly used substances that have been reduced in size, as well as novel substances such as carbon nanotubes and other exotic materials.
Growing external pressures from both the public sector and nongovernmental organizations (NGOs) suggest the need for socially-responsible behavior regarding the development and implementation of nanotechnology-driven products. Of particular interest are risk evaluations of environmental and human health impacts posed by nanoparticle technologies.
The required testing for all of our drugs ensures that nano-based pharmaceuticals are safe and effective for patient use. Our health and safety professionals closely monitor developments in the area of nanotechnology and pharmaceuticals.
Based on the current scientific body of knowledge for nanoparticles, our existing methods of assessing risks and applying controls are appropriate for effectively managing exposures to employees and the environment.
Below are two examples of how we use nanotechnology:
Human Health: The manufacturing process for EMEND® (aprepitant) uses a nanoscale milling approach to generate very small granules (with some in the “nano” range), allowing for easier absorption by the digestive tract.
Animal Health: Nanoscale milling is used for the active ingredient in PANACUR® (fenbendazole), resulting in a formulation that provides improved dosing and makes the product easier to administer.